Oligometastasis in Prostate Cancer: Can We Learn from Those “Excluded” from a Phase 2 Trial?

We conducted and previously published a phase 2 trial of metastasis-directed therapy (MDT) in men with recurrence of prostate cancer at a low prostate-specific antigen level following radical prostatectomy and postoperative radiotherapy. All patients had negative conventional imaging and underwent p...

Descripción completa

Detalles Bibliográficos
Autores principales: Glicksman, Rachel M., Murad, Vanessa, Santiago, Anna T., Liu, Zhihui, Ramotar, Matthew, Metser, Ur, Berlin, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Brief Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240507/
https://www.ncbi.nlm.nih.gov/pubmed/37284049
http://dx.doi.org/10.1016/j.euros.2023.03.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240507/
https://www.ncbi.nlm.nih.gov/pubmed/37284049
http://dx.doi.org/10.1016/j.euros.2023.03.016

Ejemplares similares